The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Perspectives on NMR in drug discovery: a technique comes of age
Open accessAbstract
In the past decade, the potential of harnessing the ability of nuclear magnetic resonance (NMR) spectroscopy to monitor intermolecular interactions as a tool for drug discovery has been increasingly appreciated in academia and industry. In this Perspective, we highlight some of the major applications of NMR in drug discovery, focusing on hit and lead generation, and provide a critical analysis of its current and potential utility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Angewandte Chemie International Edition
(2006) · Angewandte Chemie International Edition · doi:10.1002/(issn)1521-3773 · Cited by 5,242
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Pervushin, K., Riek, R., Wider, G., & Wüthrich, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12366 · Cited by 2,445
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,041
Ligand efficiency: a useful metric for lead selection
Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,846
Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy
Mayer, M., & Meyer, B. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990614)38:12<1784::aid-anie1784>3.0.co;2-q · Cited by 1,595
Self-citationVirtual screening of chemical libraries
Shoichet, B. K. (2004) · Nature · doi:10.1038/nature03197 · Cited by 1,425
A ‘Rule of Three’ for fragment-based lead discovery?
Congreve, M., Carr, R., Murray, C., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,354
Mayer, M., & Meyer, B. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0100120 · Cited by 1,200
Self-citationA decade of fragment-based drug design: strategic advances and lessons learned
Hajduk, P. J., & Greer, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2220 · Cited by 1,064
Price, W. S. (1997) · Concepts in Magnetic Resonance · doi:10.1002/(sici)1099-0534(1997)9:5<299::aid-cmr2>3.0.co;2-u · Cited by 1,020
Structure of a protein determined by solid-state magic-angle-spinning NMR spectroscopy
Castellani, F., van Rossum, B., Diehl, A., Schubert, M., Rehbein, K., & Oschkinat, H. (2002) · Nature · doi:10.1038/nature01070 · Cited by 910
Self-citationThe maximal affinity of ligands
Kuntz, I. D., Chen, K., Sharp, K. A., & Kollman, P. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.9997 · Cited by 849
Rees, D. C., Congreve, Murray, C. W., & Carr, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1467 · Cited by 798
The role of dynamics in allosteric regulation
Kern, D., & Zuiderweg, E. R. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.10.008 · Cited by 661
Erlanson, D. A., McDowell, R. S., & O'Brien, T. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040031v · Cited by 642
THE USE OF2H,13C,15N MULTIDIMENSIONAL NMR GTO STUDY THE STRUCTURE AND DYNAMICS OF PROTEINS
Gardner, K. H., & Kay, L. E. (1998) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.27.1.357 · Cited by 598
WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability
Dalvit, C., Fogliatto, G., Stewart, A., Veronesi, M., & Stockman, B. (2001) · Journal of Biomolecular NMR · doi:10.1023/a:1013302231549 · Cited by 562
Self-citationPrice, W. S. (1998) · Concepts in Magnetic Resonance · doi:10.1002/(sici)1099-0534(1998)10:4<197::aid-cmr1>3.0.co;2-s · Cited by 538
Ligand efficiency indices as guideposts for drug discovery
Abad-Zapatero, C., & Metz, J. T. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03386-6 · Cited by 527
Druggability Indices for Protein Targets Derived from NMR-Based Screening Data
Hajduk, P. J., Huth, J. R., & Fesik, S. W. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049131r · Cited by 522
Goto, N. K., Gardner, K. H., Mueller, G. A., Willis, R. C., & Kay, L. E. (1999) · Journal of Biomolecular NMR · doi:10.1023/a:1008393201236 · Cited by 512
Comprehensive medicinal chemistry II
Taylor, J. B. (2007) · Cited by 468
Dalvit, C., Pevarello, P., Tatò, M., Veronesi, M., Vulpetti, A., & Sundström, M. (2000) · Journal of Biomolecular NMR · doi:10.1023/a:1008354229396 · Cited by 466
Self-citationDevelopment and validation of a modular, extensible docking program: DOCK 5
Moustakas, D. T., Lang, P. T., Pegg, S., Pettersen, E., Kuntz, I. D., Brooijmans, N., & Rizzo, R. C. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9060-4 · Cited by 440
Fragment-Based Lead Discovery Using X-ray Crystallography
Hartshorn, M. J., Murray, C. W., Cleasby, A., Frederickson, M., Tickle, I. J., & Jhoti, H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0495778 · Cited by 422
Pellecchia, M., Sem, D. S., & Wüthrich, K. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd748 · Cited by 420
Self-citationResidual Dipolar Couplings in Structure Determination of Biomolecules
Prestegard, J. H., Bougault, C. M., & Kishore, A. I. (2004) · Chemical Reviews · doi:10.1021/cr030419i · Cited by 416
Weak alignment offers new NMR opportunities to study protein structure and dynamics
Bax, A. (2003) · Protein Science · doi:10.1110/ps.0233303 · Cited by 400
Tethering: Fragment-Based Drug Discovery
Erlanson, D. A., Wells, J. A., & Braisted, A. C. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.140409 · Cited by 385
Hajduk, P. J., Olejniczak, E. T., & Fesik, S. W. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9715962 · Cited by 371
Privileged Molecules for Protein Binding Identified from NMR-Based Screening
Hajduk, P. J., Bures, M., Praestgaard, J., & Fesik, S. W. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000164q · Cited by 351
Molecular recycling within amyloid fibrils
Carulla, N., Caddy, G. L., Hall, D. R., Zurdo, J., Gairí, M., Feliz, M., Giralt, E., Robinson, C. V., & Dobson, C. M. (2005) · Nature · doi:10.1038/nature03986 · Cited by 348
Self-citationFragment-based lead discovery: leads by design
Carr, R. A. E., Congreve, M., Murray, C. W., & Rees, D. C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03511-7 · Cited by 343
Structure-Based Discovery of Inhibitors of Thymidylate Synthase
Shoichet, B. K., Stroud, R. M., Santi, D. V., Kuntz, I. D., & Perry, K. M. (1993) · Science · doi:10.1126/science.8451640 · Cited by 322
Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR
Hajduk, P. J., Sheppard, G., Nettesheim, D. G., Olejniczak, E. T., Shuker, S. B., Meadows, R. P., Steinman, D. H., Carrera, G. M., Marcotte, P. A., Severin, J., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9702778 · Cited by 317
Methods and Principles in Medicinal Chemistry
(2007) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527610907.scard · Cited by 298
Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x L from NMR and Parallel Synthesis
Petros, A. M., Dinges, J., Augeri, D. J., Baumeister, S. A., Betebenner, D. A., Bures, M. G., Elmore, S. W., Hajduk, P. J., Joseph, M. K., Landis, S. K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0507532 · Cited by 292
NMR studies of protein structure and dynamics
Kay, L. E. (2005) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2004.11.021 · Cited by 284
The SHAPES strategy: an NMR-based approach for lead generation in drug discovery
Fejzo, J., Lepre, C. A., Peng, J. W., Bemis, G. W., Ajay, Murcko, M. A., & Moore, J. M. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(00)80022-8 · Cited by 271
Self-citationFragment-Based Drug Design: How Big Is Too Big?
Hajduk, P. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060511h · Cited by 265
Dalvit, C., Fagerness, P. E., Hadden, D. T. A., Sarver, R. W., & Stockman, B. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034646d · Cited by 248
Self-citationMetabolomics: Available Results, Current Research Projects in Breast Cancer, and Future Applications
Claudino, W. M., Quattrone, A., Biganzoli, L., Pestrin, M., Bertini, I., & Di Leo, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7550 · Cited by 246
Self-citationSegmental Isotope Labeling for Protein NMR Using Peptide Splicing
Yamazaki, T., Otomo, T., Oda, N., Kyogoku, Y., Uegaki, K., Ito, N., Ishino, Y., & Nakamura, H. (1998) · Journal of the American Chemical Society · doi:10.1021/ja980776o · Cited by 234
Szczepankiewicz, B. G., Liu, G., Hajduk, P. J., Abad-Zapatero, C., Pei, Z., Xin, Z., Lubben, T. H., Trevillyan, J. M., Stashko, M. A., Ballaron, S. J., et al. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0296733 · Cited by 231
Selenko, P., Serber, Z., Gadea, B., Ruderman, J., & Wagner, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604667103 · Cited by 229
NMR-based screening in drug discovery
Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1999) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500003528 · Cited by 229
Huth, J. R., Mendoza, R., Olejniczak, E. T., Johnson, R. W., Cothron, D. A., Liu, Y., Lerner, C. G., Chen, J., & Hajduk, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0455547 · Cited by 228
NMR screening techniques in drug discovery and drug design
Stockman, B. J., & Dalvit, C. (2002) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/s0079-6565(02)00049-3 · Cited by 227
Self-citationSolution NMR of membrane proteins: practice and challenges
Sanders, C. R., & Sönnichsen, F. (2006) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.1816 · Cited by 227
High-Throughput Nuclear Magnetic Resonance-Based Screening
Hajduk, P. J., Gerfin, T., Boehlen, J.-M., Häberli, M., Marek, D., & Fesik, S. W. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9901475 · Cited by 184
Fragment‐based Approaches in Drug Discovery
(2006) · Methods and Principles in Medicinal Chemistry · doi:10.1002/3527608761 · Cited by 181
NMR-Based Characterization of Phenothiazines as a RNA Binding Scaffold
Mayer, M., & James, T. L. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0398870 · Cited by 180
Self-citationReduced-dimensionality NMR spectroscopy for high-throughput protein resonance assignment
Szyperski, T., Yeh, D. C., Sukumaran, D. K., Moseley, H., & Montelione, G. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122224599 · Cited by 175
Chris Lipinski discusses life and chemistry after the Rule of Five
Owens, J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02556-4 · Cited by 171
The INPHARMA Method: Protein‐Mediated Interligand NOEs for Pharmacophore Mapping
Sánchez‐Pedregal, V. M., Reese, M., Meiler, J., Blommers, M. J. J., Griesinger, C., & Carlomagno, T. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500503 · Cited by 170
Solution NMR spectroscopy beyond 25 kDa
Kay, L. E., & Gardner, K. H. (1997) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(97)80084-x · Cited by 169
Pervushin, K. (2000) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500003619 · Cited by 163
Romanelli, A., Shekhtman, A., Cowburn, D., & Muir, T. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306616101 · Cited by 163
Self-citationWater, water everywhere — except where it matters?
Homans, S. W. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.05.004 · Cited by 159
Self-citationNMR Characterization of Kinase p38 Dynamics in Free and Ligand‐Bound Forms
Vogtherr, M., Saxena, K., Hoelder, S., Grimme, S., Betz, M., Schieborr, U., Pescatore, B., Robin, M., Delarbre, L., Langer, T., et al. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502770 · Cited by 145
Self-citationConformational variability of matrix metalloproteinases: Beyond a single 3D structure
Bertini, I., Calderone, V., Cosenza, M., Fragai, M., Lee, Y., Luchinat, C., Mangani, S., Terni, B., & Turano, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407106102 · Cited by 141
Self-citationCastellani, F., van Rossum, B., Diehl, A., Rehbein, K., & Oschkinat, H. (2003) · Biochemistry · doi:10.1021/bi034903r · Cited by 141
Self-citationThe effect of relaxation on the epitope mapping by saturation transfer difference NMR
Yan, J., Kline, A. D., Mo, H., Shapiro, M. J., & Zartler, E. R. (2003) · Journal of Magnetic Resonance · doi:10.1016/s1090-7807(03)00106-x · Cited by 140
Rutenber, E. E., Fauman, E. B., Keenan, R. J., Fong, S., Furth, P. S., de Montellano, P. R. O., Meng, E., Kuntz, I. D., DeCamp, D. L., & Salto, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82261-x · Cited by 135
Diversity screening versus focussed screening in drug discovery
Valler, M. J., & Green, D. V. S. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01517-8 · Cited by 130
Züger, S., & Iwaï, H. (2005) · Nature Biotechnology · doi:10.1038/nbt1097 · Cited by 129
Spin Label Enhanced NMR Screening
Jahnke, W., Rüdisser, S., & Zurini, M. G. M. (2001) · Journal of the American Chemical Society · doi:10.1021/ja005836g · Cited by 129
Self-citationEfficient synthetic inhibitors of anthrax lethal factor
Forino, M., Johnson, S. L., Wong, T. Y., Rozanov, D. V., Savinov, A. Y., Li, W., Fattorusso, R., Becattini, B., Orry, A. J. W., Jung, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502733102 · Cited by 128
Self-citationNMR studies of protein interactions
Takeuchi, K., & Wagner, G. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.01.006 · Cited by 128
A General NMR Method for Rapid, Efficient, and Reliable Biochemical Screening
Dalvit, C., Ardini, E., Flocco, M. M., et al. (2003) · Journal of the American Chemical Society · doi:10.1021/ja038128e · Cited by 122
Self-citationNMR data collection and analysis protocol for high-throughput protein structure determination
Liu, G., Shen, Y., Atreya, H. S., Parish, D., Shao, Y., Sukumaran, D. K., Xiao, R., Yee, A. A., Lemak, A. S., Bhattacharya, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504338102 · Cited by 117
High-Resolution Solid-State NMR Applied to Polypeptides and Membrane Proteins
Luca, S., Heise, H., & Baldus, M. (2003) · Accounts of Chemical Research · doi:10.1021/ar020232y · Cited by 114
Fragonomics: fragment-based drug discovery
Zartler, E. R., & Shapiro, M. J. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.05.002 · Cited by 104
Targeting Apoptosis via Chemical Design
Becattini, B., Sareth, S., Zhai, D., Crowell, K. J., Leone, M., Reed, J. C., & Pellecchia, M. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.05.022 · Cited by 98
Self-citationBecattini, B., Culmsee, C., Leone, M., Zhai, D., Zhang, X., Crowell, K. J., Rega, M. F., Landshamer, S., Reed, J. C., Plesnila, N., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603460103 · Cited by 94
Self-citationDalvit, C., Flocco, M. M., Veronesi, M., & Stockman, B. J. (2002) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207023329923 · Cited by 91
Self-citationMayer, M., & James, T. L. (2002) · Journal of the American Chemical Society · doi:10.1021/ja027526z · Cited by 90
Self-citationHajduk, P. J., Mack, J. C., Olejniczak, E. T., Park, C., Dandliker, P. J., & Beutel, B. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja039480v · Cited by 90
Second-Site NMR Screening with a Spin-Labeled First Ligand
Jahnke, W., Perez, L. B., PARIS, C. G., Strauss, A., Fendrich, G., & Nalin, C. M. (2000) · Journal of the American Chemical Society · doi:10.1021/ja001241+ · Cited by 85
Self-citationProtein NMR in biomedical research
Jahnke, W., & Widmer, H. M. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3382-3 · Cited by 84
Self-citationOligomeric Structure, Dynamics, and Orientation of Membrane Proteins from Solid-State NMR
Hong, M. (2006) · Structure · doi:10.1016/j.str.2006.10.002 · Cited by 82
NMR-based techniques in the hit identification and optimisation processes
Pellecchia, M., Becattini, B., Crowell, K. J., Fattorusso, R., Forino, M., Fragai, M., Jung, D., Mustelin, T., & Tautz, L. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.597 · Cited by 77
Self-citationCross-Correlated Relaxation for Measurement of Angles between Tensorial Interactions
Schwalbe, H., Carlomagno, T., Hennig, M., Junker, J., Reif, B., Richter, C. P., & Griesinger, C. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)38215-6 · Cited by 75
Self-citationExploring the Subtleties of Drug−Receptor Interactions: The Case of Matrix Metalloproteinases
Bertini, I., Calderone, V., Fragai, M., Giachetti, A., Loconte, M., Luchinat, C., Maletta, M., Nativi, C., & Yeo, K. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja065156z · Cited by 75
Self-citationThe Natural Product Berberine is a Human Prolyl Oligopeptidase Inhibitor
Tarragó, T., Kichik, N., Seguí, J., & Giralt, E. (2007) · ChemMedChem · doi:10.1002/cmdc.200600303 · Cited by 74
Self-citationReliable high-throughput functional screening with 3-FABS
Dalvit, C., Ardini, E., Fogliatto, G., Mongelli, N., & Veronesi, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03161-7 · Cited by 72
Self-citationDiffusion NMR Spectroscopy: Folding and Aggregation of Domains in p53
Dehner, A., & Kessler, H. (2005) · ChemBioChem · doi:10.1002/cbic.200500093 · Cited by 72
Self-citationDalvit, C., Mongelli, N., Papeo, G., Giordano, P., Veronesi, M., Moskau, D., & Kümmerle, R. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0542385 · Cited by 66
Self-citationNMR-based screening: a powerful tool in fragment-based drug discovery
Klages, J., Coles, M. P., & Kessler, H. (2007) · The Analyst · doi:10.1039/b709658p · Cited by 63
Self-citationDalvit, C., Caronni, D., Mongelli, N., Veronesi, M., & Vulpetti, A. (2006) · Current Drug Discovery Technologies · doi:10.2174/157016306778108875 · Cited by 63
Self-citationIntegration of NMR and High-Throughput Screening
Hajduk, P. J., & Burns, D. J. (2002) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207023329996 · Cited by 63
An approach for high-throughput structure determination of proteins by NMR spectroscopy
Medek, A., Olejniczak, E. T., Meadows, R. P., & Fesik, S. W. (2000) · Journal of Biomolecular NMR · doi:10.1023/a:1026544801001 · Cited by 62
Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly
Erlanson, D. A., & Hansen, S. K. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.06.010 · Cited by 61
Langer, T., Vogtherr, M., Elshorst, B., Betz, M., Schieborr, U., Saxena, K., & Schwalbe, H. (2004) · ChemBioChem · doi:10.1002/cbic.200400129 · Cited by 60
Self-citationAllen, K. N., Lavie, A., Petsko, G. A., & Ringe, D. (1995) · Biochemistry · doi:10.1021/bi00011a032 · Cited by 58
NMR-based methods and strategies for drug discovery
Salvatella, X., & Giralt, E. (2003) · Chemical Society Reviews · doi:10.1039/b210047a · Cited by 55
Self-citationReckel, S., Löhr, F., & Dötsch, V. (2005) · ChemBioChem · doi:10.1002/cbic.200500076 · Cited by 52
A Fragment-Based Approach for the Discovery of Isoform-Specific p38α Inhibitors
Chen, J., Zhang, Z., Stebbins, J. L., Zhang, X., Hoffman, R., Moore, A., & Pellecchia, M. (2007) · ACS Chemical Biology · doi:10.1021/cb700025j · Cited by 51
Self-citationApplication of NMR SHAPES Screening to an RNA Target
Johnson, E. C., Feher, V. A., Peng, J. W., Moore, J. M., & Williamson, J. R. (2003) · Journal of the American Chemical Society · doi:10.1021/ja037499s · Cited by 49
Self-citationHow Much NMR Data Is Required To Determine a Protein–Ligand Complex Structure?
Schieborr, U., Vogtherr, M., Elshorst, B., Betz, M., Grimme, S., Pescatore, B., Langer, T., Saxena, K., & Schwalbe, H. (2005) · ChemBioChem · doi:10.1002/cbic.200500092 · Cited by 48
Self-citationGill, A. L., Cleasby, A., & Jhoti, H. (2005) · ChemBioChem · doi:10.1002/cbic.200400188 · Cited by 46
Applications of SHAPES Screening in Drug Discovery
Lepre, C. A., Peng, J. W., Fejzo, J., Abdul-Manan, N., Pocas, J. R., Jacobs, M. D., Xie, X., & Moore, J. M. (2002) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207023329950 · Cited by 43
Self-citationCharacterization of Protein−Ligand Interactions by High-Resolution Solid-State NMR Spectroscopy
Zech, S. G., Olejniczak, E. T., Hajduk, P. J., Mack, J. C., & McDermott, A. E. (2004) · Journal of the American Chemical Society · doi:10.1021/ja040086m · Cited by 43
Bertini, I., Fragai, M., Giachetti, A., Luchinat, C., Maletta, M., Parigi, G., & Yeo, K. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050574k · Cited by 41
Self-citationBiomolecular NMR: a chaperone to drug discovery
Betz, M., Saxena, K., & Schwalbe, H. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.04.006 · Cited by 40
Self-citationTaylor, J. D., Gilbert, P. J., Williams, M. A., Pitt, W. R., & Ladbury, J. E. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21369 · Cited by 39
Contribution of Ligand Desolvation to Binding Thermodynamics in a Ligand–Protein Interaction
Shimokhina, N., Bronowska, A. K., & Homans, S. W. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602227 · Cited by 39
Self-citationA Tetraguanidinium Ligand Binds to the Surface of the Tetramerization Domain of Protein P53
Salvatella, X., Martinell, M., Gairí, M., Mateu, M. G., Feliz, M., Hamilton, A. D., de Mendoza, J., & Giralt, E. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200352115 · Cited by 38
Self-citationCombined solid state and solution NMR studies of α,ɛ-15N labeled bovine rhodopsin
Werner, K., Lehner, I., Dhiman, H. K., Richter, C. P., Glaubitz, C., Schwalbe, H., Klein‐Seetharaman, J., & Khorana, H. G. (2007) · Journal of Biomolecular NMR · doi:10.1007/s10858-007-9143-0 · Cited by 37
Self-citationVázquez, J., Tautz, L., Ryan, J. J., Vuori, K., Mustelin, T., & Pellecchia, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061481l · Cited by 36
Self-citationKoglin, A., Klammt, C., Trbovic, N., Schwarz, D. F., Schneider, B., Schäfer, B., Löhr, F., Bernhard, F., & Dötsch, V. (2006) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.1833 · Cited by 35
Wang, B., Westerhoff, L. M., & Merz, K. M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070484a · Cited by 35
Dalvita, C. C., Flocco, M. M., Stockman, B. J., & Veronesi, M. (2002) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207023329905 · Cited by 34
Maximizing discovery efficiency with a computationally driven fragment approach.
Moore, W. R. (2005) · PubMed · Cited by 32
Traditional Chinese medicines with caspase-inhibitory activity
Fattorusso, R., Frutos, S., Sun, X., Sucher, N. J., & Pellecchia, M. (2005) · Phytomedicine · doi:10.1016/j.phymed.2005.03.004 · Cited by 31
Self-citationPhosphorus NMR Spectroscopy as a Versatile Tool for Compound Library Screening
Manzenrieder, F., Frank, A. O., & Kessler, H. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705256 · Cited by 31
Self-citationRutenber, E. E., McPhee, F., Kaplan, A. P., Gallion, S. L., Hogan, J. C., Craik, C. S., & Stroud, R. M. (1996) · Bioorganic & Medicinal Chemistry · doi:10.1016/0968-0896(96)00147-2 · Cited by 29
Frutos, S., Rodríguez‐Mias, R. A., Madurga, S., Collinet, B., Reboud‐Ravaux, M., Ludevid, M. D., & Giralt, E. (2007) · Biopolymers · doi:10.1002/bip.20685 · Cited by 24
Self-citationConformational Analysis of Drugs by Nuclear Magnetic Resonance Spectroscopy
Luy, B., Frank, A. O., & Kessler, H. (2007) · Methods and principles in medicinal chemistry · doi:10.1002/9783527621286.ch9 · Cited by 16
Self-citationNMR in Pharmacokinetic and Pharmacodynamic Profiling
Sun, C. C., Huth, J. R., & Hajduk, P. J. (2005) · ChemBioChem · doi:10.1002/cbic.200500028 · Cited by 15
Cited by
Emerging principles in protease-based drug discovery
Drag, M., & Salvesen, G. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3053 · Cited by 601
An introduction to NMR-based approaches for measuring protein dynamics
Kleckner, I. R., & Foster, M. P. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.10.012 · Cited by 561
Cryo-EM in drug discovery: achievements, limitations and prospects
Renaud, J.-P., Chari, A., Ciferri, C., Liu, W.-T., Rémigy, H.-W., Stark, H., & Wiesmann, C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.77 · Cited by 461
Nmrglue: an open source Python package for the analysis of multidimensional NMR data
Helmus, J. J., & Jaroniec, C. P. (2013) · Journal of Biomolecular NMR · doi:10.1007/s10858-013-9718-x · Cited by 383
Biophysics in drug discovery: impact, challenges and opportunities
Renaud, J.-P., Chung, C.-W., Danielson, U. H., Egner, U., Hennig, M., Hubbard, R. E., & Nar, H. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.123 · Cited by 382
Metadata
- Authors
- Pellecchia, M., Bertini, I., Cowburn, D., Dalvit, C., Giralt, E., Jahnke, W., James, T. L., Homans, S. W., Kessler, H., Luchinat, C., Meyer, B., Oschkinat, H., Peng, J., Schwalbe, H., & Siegal, G.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-09
- Volume
- 7
- Issue
- 9
- Pages
- 738-745
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2037959733
- Cited by
- 414
- References
- 124
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.